RU2104698C1 - Способ лечения патологических отклонений при диабете типа ii - Google Patents

Способ лечения патологических отклонений при диабете типа ii Download PDF

Info

Publication number
RU2104698C1
RU2104698C1 RU94037557A RU94037557A RU2104698C1 RU 2104698 C1 RU2104698 C1 RU 2104698C1 RU 94037557 A RU94037557 A RU 94037557A RU 94037557 A RU94037557 A RU 94037557A RU 2104698 C1 RU2104698 C1 RU 2104698C1
Authority
RU
Russia
Prior art keywords
insulin
subject
dopamine agonist
daily
prolactin
Prior art date
Application number
RU94037557A
Other languages
English (en)
Russian (ru)
Other versions
RU94037557A (ru
Inventor
Х.Кинкотта Энтони
Х.Мэйер Алберт
Original Assignee
Дзе Борд оф Сьюпервайзорз оф Луизиана Стейт Юниверсити энд Эгрикалчурал энд Мекэникал Колледж
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Дзе Борд оф Сьюпервайзорз оф Луизиана Стейт Юниверсити энд Эгрикалчурал энд Мекэникал Колледж filed Critical Дзе Борд оф Сьюпервайзорз оф Луизиана Стейт Юниверсити энд Эгрикалчурал энд Мекэникал Колледж
Publication of RU94037557A publication Critical patent/RU94037557A/ru
Application granted granted Critical
Publication of RU2104698C1 publication Critical patent/RU2104698C1/ru

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/48—Ergoline derivatives, e.g. lysergic acid, ergotamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
RU94037557A 1991-12-23 1992-12-22 Способ лечения патологических отклонений при диабете типа ii RU2104698C1 (ru)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US813135 1985-12-24
US81313591A 1991-12-23 1991-12-23
US813.135 1991-12-23
PCT/US1992/011166 WO1993012793A1 (fr) 1991-12-23 1992-12-22 Procede therapeutique de traitement de pathologies du diabete de type ii

Publications (2)

Publication Number Publication Date
RU94037557A RU94037557A (ru) 1996-05-20
RU2104698C1 true RU2104698C1 (ru) 1998-02-20

Family

ID=25211542

Family Applications (1)

Application Number Title Priority Date Filing Date
RU94037557A RU2104698C1 (ru) 1991-12-23 1992-12-22 Способ лечения патологических отклонений при диабете типа ii

Country Status (5)

Country Link
AU (1) AU3419293A (fr)
CZ (1) CZ282909B6 (fr)
HU (1) HUT67688A (fr)
RU (1) RU2104698C1 (fr)
WO (1) WO1993012793A1 (fr)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5585347A (en) * 1988-05-10 1996-12-17 Ergo Science Incorporated Methods for the determination and adjustment of prolactin daily rhythms
US5744477A (en) * 1988-05-10 1998-04-28 The Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College Method for treatment of obesity using prolactin modulators and diet
US5696128A (en) * 1994-07-07 1997-12-09 The Board Of Supervisors Of Louisiana University And Agricultural And Mechanical College Method of regulating immune function
IL112106A0 (en) * 1993-12-22 1995-03-15 Ergo Science Inc Accelerated release composition containing bromocriptine
DE69736928T2 (de) * 1996-05-07 2007-06-28 Pliva Istrazivanje I Razvoj D.O.O. Verfahren und zusammensetzung zur behandlung von stoerungen des fett- und glukosemetabolismus
US9655865B2 (en) * 2002-07-29 2017-05-23 Veroscience, Llc Therapeutic treatment for metabolic syndrome, type 2 diabetes, obesity, or prediabetes
US8821915B2 (en) 2002-08-09 2014-09-02 Veroscience, Llc Therapeutic process for the treatment of the metabolic syndrome and associated metabolic disorders
AU2013263800B2 (en) * 2007-03-30 2016-05-05 Veroscience Llc Methods of treating metabolic syndrome using dopamine receptor agonists
WO2009062113A1 (fr) * 2007-11-07 2009-05-14 Burnham Institute For Medical Research Procédé et composés pour la régulation de la production d'insuline
US9352025B2 (en) 2009-06-05 2016-05-31 Veroscience Llc Combination of dopamine agonists plus first phase insulin secretagogues for the treatment of metabolic disorders
AU2014277952A1 (en) * 2013-06-13 2016-01-28 Veroscience Llc Compositions and methods for treating metabolic disorders

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4659715A (en) * 1986-03-07 1987-04-21 Louisiana State University And Agricultural And Mechanical College Method of inhibiting body fat stores
DE3722383A1 (de) * 1986-07-14 1988-01-28 Sandoz Ag Neue verwendung von bromocriptin

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
Буйдина Т.А. - Новости медицины и фармации, 1994, N 3, с. 16 - 20. *

Also Published As

Publication number Publication date
HU9401900D0 (en) 1994-09-28
CZ282909B6 (cs) 1997-11-12
RU94037557A (ru) 1996-05-20
WO1993012793A1 (fr) 1993-07-08
HUT67688A (en) 1995-04-28
AU3419293A (en) 1993-07-28
CZ155494A3 (en) 1995-08-16

Similar Documents

Publication Publication Date Title
US5468755A (en) Therapeutic process for the treatment of the pathologies of Type II diabetes
US5866584A (en) Therapeutic process for the treatment of the pathologies of type II diabetes
US5654313A (en) Method for modifying or regulating the glucose metabolism of an animal or human subject
AU687034B2 (en) Improved methods for the determination and adjustment of prolactin daily rhythms
US5741503A (en) Method for regulating metabolism with dopamine beta hydroxylase inhibitors
US6004972A (en) Therapeutic process for the treatment of the pathologies of type II diabetes
US5744477A (en) Method for treatment of obesity using prolactin modulators and diet
RU2104698C1 (ru) Способ лечения патологических отклонений при диабете типа ii
US5830895A (en) Methods for the determination and adjustment of prolactin daily rhythms
US5716932A (en) Process for the long term reduction of body fat stores, insulin resistance, and hyperinsulinemia in vertebrates
CZ378796A3 (en) Method of determining abnormal states and adjustment of prolactin daily rhythms
MXPA97009573A (en) Method for regulating metabolism with beta hidroxil dopamine inhibitors

Legal Events

Date Code Title Description
MM4A The patent is invalid due to non-payment of fees

Effective date: 20111223